I enjoyed the article on the controversy concerning the utility of haplotypes in human disease understanding.1 My assessment is more in line with Ken Kidd's than with the fervent advocates of the HapMap.
My interest in this area dates from the 1970s and culminated in 1989–1990 with two patents concerning the utility of haplotypes marked by noncoding sequence variant markers exhibiting linkage disequilibrium